Dutanol Research Overview
Dutanol 0.5 mg manufactured by Knoll Healthcare is a pharmaceutical preparation containing dutasteride, a dual 5-alpha reductase inhibitor extensively studied in laboratory research. Dutasteride belongs to the class of 4-azasteroid compounds and functions as a potent competitive inhibitor of both Type I and Type II 5-alpha reductase enzymes. Research laboratories investigating androgen metabolism, hormonal regulation pathways, and steroid biochemistry frequently examine this compound’s mechanisms of action. When researchers Stroid UK Shop, dutasteride provides valuable insights into dihydrotestosterone biosynthesis inhibition.
Laboratory Research Applications
Dutasteride demonstrates comprehensive inhibition of 5-alpha reductase isoforms in preclinical models, making it valuable for investigating androgen-dependent cellular processes. Laboratory studies examine its effects on testosterone conversion pathways, prostatic tissue research, and hormonal regulation mechanisms. Research applications include examining androgen receptor modulation, investigating hair follicle biology, and studying steroid metabolism pathways. Scientists studying metabolic compounds often utilise dutasteride as a reference standard. Additionally, researchers investigating selective androgen receptor modulators and peptide hormone systems may examine dutasteride’s interactions with androgen signalling cascades in controlled laboratory environments.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Dutasteride 0.5 mg |
| CAS Number | 164656-23-9 |
| Molecular Formula | C₂₇H₃₀F₆N₂O₂ |
| Molecular Weight | 528.53 g/mol |
| Manufacturer | Knoll Healthcare |
| Product Code | EU14254 |
| Storage | Room temperature, dry conditions |
| Stability | Verify with supplier |
Research Compliance Statement
Dutanol 0.5 mg is supplied exclusively for in-vitro laboratory research purposes by qualified researchers and institutions. This pharmaceutical preparation is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure compliance with applicable laboratory safety protocols, institutional guidelines, and regulatory requirements when handling this compound. All studies should be conducted within appropriate laboratory facilities with adequate safety measures and proper waste disposal procedures.
